Zevra Therapeutics (ZVRA) FCF Margin (2019 - 2026)
Zevra Therapeutics' FCF Margin was 25.95% in Q3 2026, up 10.03 percentage points from 15.92% a year earlier but down 16.41 percentage points from the prior quarter.
Zevra Therapeutics (ZVRA) FCF Margin (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Zevra Therapeutics' FCF Margin was 25.89% through Sep 30, 2026, up 54.59 percentage points year-over-year; for FY2025, it was -2.28%, up 292.76 percentage points from FY2024.
- FCF Margin shows a five-year change of +12.56 percentage points (FY2020 to FY2025).
- In earlier years, FCF Margin was -295.04% in FY2024 (-171.84 pp), -123.20% in FY2023 (+61.92 pp), -185.12% in FY2022 (-221.20 pp) and 36.08% in FY2021 (+50.92 pp).
- Quarterly FCF Margin has moved between -490.30% (Q3 2024) and 42.36% (Q2 2026) over five years.
- Compared with a year earlier, FCF Margin has increased for seven straight quarters, with an average year-over-year change of +202.35 percentage points over the last eight quarters.
- The best year-over-year quarter for FCF Margin over five years was Q3 2025 (a gain of 506.22 percentage points); the worst was Q2 2022 (a drop of 454.69 percentage points).
- Per Business Quant data, ZVRA's FCF Margin in the three quarters before Q3 2026 was 42.36% (Q2 2026), 16.86% (Q1 2026) and 16.24% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 28.96% |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 25.95% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 25.95% |
| Jun 30, 2026 | 42.36% |
| Mar 31, 2026 | 16.86% |
| Dec 31, 2025 | 16.24% |
| Sep 30, 2025 | 15.92% |
| Jun 30, 2025 | -14.73% |
| Mar 31, 2025 | -40.79% |
| Dec 31, 2024 | -135.28% |
| Sep 30, 2024 | -490.30% |
| Jun 30, 2024 | -429.51% |
| Mar 31, 2024 | -471.97% |
| Dec 31, 2023 | -125.62% |
| Sep 30, 2023 | -165.80% |
| Jun 30, 2023 | -103.03% |
| Mar 31, 2023 | -128.27% |
| Dec 31, 2022 | -222.35% |
| Sep 30, 2022 | -230.55% |
| Jun 30, 2022 | -316.85% |
| Mar 31, 2022 | -90.01% |
| Dec 31, 2021 | -33.50% |
Zevra Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=ZVRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();